← EPO Patent Bulletin

CRYSTALLINE FORMS OF 2-[3-(2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)-3H-[1,2,3]TRIAZOLO[4,5-C]PYRIDAZIN-6-YL]-5-(2H-1,2,3-TRIAZOL-2-YL)PHENOL

Publication EP4709478A1 Kind: A1 Mar 18, 2026

Applicants

PTC THERAPEUTICS, HD, INC.

Inventors

SHU, Lianhe

IPC Classifications

A61P 25/00 20060101AFI20241115BHEP C07D 487/04 20060101ALI20241115BHEP A61K 31/5025 20060101ALI20241115BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR